DongKook Pharmaceutical Co., Ltd.

₩23,550As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:086450Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 9.40%
Div yield 0.85%
ROE 10.72%
Medical (Pharmaceuticals)
Beta (5Y) (0.09)
PE TTM 13.87
TSR TTM 34.75%
Mkt cap ₩1.062T
ROIC 11.30%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩29,933
27.10%
162.10%
Hold 8|12|7|8|5
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
366.65
410.27
394.45
421.15
10.74%
16.87%
8.44%
10.16%
Revenue₩B
84.84
89.32
87.37
91.91
6.43%
10.17%
5.51%
11.47%
Peers (US$783.3M)
Cap (US$)
PE
1.117B
19.92x
1.024B
14.77x
Capital
TTM
5Y
10Y
Leveragex
1.059
1.034
0.803
EBIT/Intx
0.995
1.584
1.593
Own earn%
39.91
(41.92)
(28.52)
Sh yield%
32.96
24.90
26.89
Owners
Insiders/Inst%
8.93
69.52
Short interest%
1.05
SBC / revenue%
5.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
1–4
$1 testx
0.0
Incr. ROIC%
1